Transcriptomics

Dataset Information

0

An oncolytic virus–delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment


ABSTRACT: Oncolytic viruses (OV) are promising forms of immunotherapy that have demonstrated clinical benefit in difficult-to-treat cancers such as metastatic melanoma. However, their adoption in other malignancies has been limited, in part, due to poorly understood mechansims of therapeutic resistance. Here, bulk RNA-seq was performed on oncolytic vaccinia virus-sensitive and -resistant murine head and neck squamous cell carcinomas (MEERvvS and MEERvvR, respectively) to explore potential means of OV resistance. These results corroborated a potential role for TGF-beta mediated stabilization of immunosuppressive regulatory T cells in the tumor microenvironment of OV-resistant MEERvvR-bearing mice. Subsequently, treatment with oncolytic vaccinia virus engineered to expess a dominant negative TGF-β signaling inhibitor (VVtgfbi) restored sensitivity to OV-mediated cell death among MEERvvR tumors. Single-cell RNA seq performed on CD45+ immune cells isolated from tumors suggests TGF-β inhibition may also reduce the presence and activity of myeloid-derived suppressor cell populations within the tumor microenvironment.

ORGANISM(S): Mus musculus

PROVIDER: GSE188506 | GEO | 2023/07/27

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2016-03-01 | GSE76208 | GEO
2016-03-01 | E-GEOD-76208 | biostudies-arrayexpress
2020-07-29 | GSE155247 | GEO
2023-01-27 | GSE223395 | GEO
2018-11-10 | GSE122358 | GEO
2024-10-15 | GSE274509 | GEO
2024-10-15 | GSE274508 | GEO
| PRJNA779090 | ENA
2019-11-30 | GSE137757 | GEO
2022-01-03 | E-MTAB-9826 | biostudies-arrayexpress